Cause of death, by non-communicable diseases, ages 5-14, male in Serbia
Serbia: Cause of death, by non-communicable diseases, ages 5-14, male was 62.7% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 5-14, male in Serbia, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 5-14.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 5-14, male in Serbia stood at 62.7%.
The figure is down 8.4% on the previous year and up 25.7% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14, male in Serbia peaked at 68.5% in 2020 and was at its lowest, 48.1%, in 2000.
Serbia ranks 23rd of 185 countries on this measure, in the top quarter.
Cause of death, by non-communicable diseases, ages 5-14, male in Serbia, year by year
| Year | % of total male deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 48.1% | — |
| 2010 | 49.9% | +3.8% |
| 2015 | 61.5% | +23.3% |
| 2019 | 57.7% | -6.2% |
| 2020 | 68.5% | +18.7% |
| 2021 | 62.7% | -8.4% |
Serbia compared with similar countries
- Serbia's 62.7% is above the median for upper middle income countries, which is 37.2%, 1.7× the median. (55 countries reporting)
- Serbia's 62.7% is above the median for Europe & Central Asia, which is 54.5%, 1.2× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 48.1% | 48.1% | 48.1% | 1 |
| 2010s | 56.4% | 49.9% | 61.5% | 3 |
| 2020s | 65.6% | 62.7% | 68.5% | 2 |
Countries ranked near Serbia
More health data for Serbia
- Un projection of annual infant deaths, annual growth rate -5.26 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3584 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,502 deaths per 1,000 people (2090)
- Number of infants who die before age 1 18 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.67 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.022 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.67 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14, male in Serbia?
- Cause of death, by non-communicable diseases, ages 5-14, male in Serbia was 62.7% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14, male recorded in Serbia?
- The highest recorded value was 68.5% in 2020.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14, male recorded in Serbia?
- The lowest recorded value was 48.1% in 2000.
- How does Serbia rank for cause of death, by non-communicable diseases, ages 5-14, male?
- Serbia ranks 23rd out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14, male rising or falling in Serbia?
- Over the last ten years it is up 25.7%. The long-run trend across the full record is rising.
- Where does this Serbia data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.